跳至主要内容
临床试验/NCT07029464
NCT07029464尚未招募不适用

Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

The First Affiliated Hospital of Nanchang University0 个研究点目标入组 4,000 人开始时间: 2025年6月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
4,000
主要终点
3-year overall survival (OS) rate and 3-year disease-free survival (DFS) rate

研究概览

简要总结

This is a retrospective, multicenter cohort study to compare short- and long-term outcomes between robotic and laparoscopic hemicolectomy of right colon cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1.Underwent radical right hemicolectomy by Da Vinci robotic or laparoscopic surgery 2.Postoperative pathology confirmed right colon adenocarcinoma (pT2-T4aNxM0; including cecal adenocarcinoma, ascending colon adenocarcinoma, hepatic flexure colon adenocarcinoma, and proximal transverse colon adenocarcinoma) 3.Complete clinical data and pathological results available

排除标准

  • 1.Received neoadjuvant therapy prior to surgery 2.History of other malignancies in the past 5 years (except cured cervical carcinoma in situ, basal cell carcinoma, or squamous cell carcinoma of the skin) 3.Distant metastases (e.g., liver, lung) or extensive abdominal/pelvic metastases confirmed by contrast-enhanced CT, PET-CT, or intraoperative exploration 4.Comorbid neurological/psychiatric disorders impairing ability to express informed consent 5.Poor systemic condition with contraindications to general anesthesia 6.Severe obesity (BMI >35 kg/m²) 7.Severe widespread abdominal adhesions precluding safe pneumoperitoneum establishment 8.Emergency surgery due to tumor perforation or obstruction 9.Refusal to provide informed consent

结局指标

主要结局

3-year overall survival (OS) rate and 3-year disease-free survival (DFS) rate

时间窗: (OS)From post-operation until death or the 3-year study endpoint (DFS)From post-operation to tumor recurrence or the 3-year study endpoint

次要结局

  • Operative time(Periprocedural)
  • Intraoperative blood loss(Periprocedural)
  • Time to first flatus/bowel movement(Periprocedural)
  • Time to liquid diet initiation(Periprocedural)
  • Time to ambulation(Periprocedural)
  • Postoperative hospital stay duration(Up to 30 days)
  • Postoperative complications(From end of surgery to 30 days postoperatively)
  • Postoperative white blood cell (WBC) count(On postoperative days 1, 3, and 5)
  • Postoperative C-reactive protein (CRP) level(On postoperative days 1, 3, and 5)
  • Pain score(On postoperative days 1, 3, and 5)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Taiyuan Li

chief physician

The First Affiliated Hospital of Nanchang University

相似试验